Meeting Materials for the October 24-27, 2017 Scientific Advisory Panel
Meeting Postponed
Topic: Physiologically-based Pharmacokinetic Modeling
EPA postponed the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel (SAP) meeting scheduled for October 24-27, 2017 due to the unavailability of experts for the peer review panel. On December 18, 2017, the Agency published a Federal Register notice to announce the opportunity to provide additional nominations for experts to serve as ad hoc members for the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) reviewing physiologically-based pharmacokinetic (PBPK) modeling to address pharmacokinetic differences between and within species on six selected pesticidal active ingredients. The public can provide nominations until January 17, 2018. Nominations can be provided by following the instructions in the Federal Register announcement (EPA-HQ-OPP-2017-0180) or by forwarding the nomination to the Designated Federal Official listed below.
Nominations should include scientists who have sufficient professional qualifications, including training and experience, to be capable of providing expert comments on the following issues: physiologically-based pharmacokinetic (PBPK) modeling, pharmacokinetics, pharmacodynamic (PD) modeling, in vitro to in vivo extrapolation, human health risk assessment, neurotoxicity, organophosphate pesticides, pyrethroids pesticides, N-methyl carbamate pesticides, fungicides, acetylcholinesterase inhibition, and exposure assessment.
The FIFRA SAP serves as a primary scientific peer review mechanism of EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and is structured to provide scientific advice, information and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health and the environment.
Additional information may be found in the docket, on the FIFRA SAP website (https://www.epa.gov/sap) or by contacting the Designated Federal Official, Dr. Marquea D. King via email: king.marquea@epa.gov or telephone: 202-564-3626.
- Panel Members (October 24-27, 2017) (PDF)(3 pp, 75 K)
- Biosketches (October 24-27, 2017) (PDF)(9 pp, 320 K)
- Issue Paper (October 24-27, 2017) (PDF)(26 pp, 393 K)
- Charge to the Panel (October 24-27, 2017) (PDF)(7 pp, 225 K)
- Transmittal Memo of Background Materials on the Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model on Acibenzolar (PDF)(22 pp, 336 K)
- Acibenzolar White Paper (PDF) (64 pp, 1 M)
- Instructions for Obtaining a Copy of the Record (PDF) (1 pp, 7 K)
- Transmittal Memo of Background Materials on the Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model on Carbaryl (PDF)(6 pp, 258 K)
- Carbaryl Background Materials (ZIP)(66 files, 6.7 M)
- Transmittal Memo of Background Materials on the Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model on Deltamethrin and cis-Permethrin (PDF)(9 pp, 364 K)
- Deltamethrin and cis-Permethrin Background Materials (ZIP)(173 files, 10.6 M)
- Transmittal Memo of Background Materials on the Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model on Dimethoate (PDF)(3 pp, 219 K)
- Dimethoate Background Materials (ZIP)(11 files, 70 M)
- Transmittal Memo of Background Materials on the Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model on Malathion (PDF)(19 pp, 351 K)
- Malathion Background Materials (ZIP)(107 files, 126 M)